News Shortcuts from other journals

Antiobesity drug rimonabant linked to anxiety and depression

BMJ 2007; 335 doi: (Published 22 November 2007) Cite this as: BMJ 2007;335:1070

Two recent reports have uncovered a worrying link between the antiobesity drug rimonabant and mental health problems, including suicide, says an editorial (p 1671). The first, a meta-analysis of four key trials, found that obese people who took the drug were two and half …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial